Location History:
- Upsala, SE (1996)
- 57 Uppsala, SE (1994 - 1998)
- Uppsala, SE (1992 - 2007)
Company Filing History:
Years Active: 1992-2007
Title: Martin K Lindberg: Innovator in Biotechnology
Introduction
Martin K Lindberg is a prominent inventor based in Upsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of proteins and polypeptides with therapeutic applications. With a total of six patents to his name, Lindberg's work has the potential to impact medical diagnostics and treatment.
Latest Patents
Lindberg's latest patents include groundbreaking inventions such as antibodies to a fibrinogen binding protein of Staphylococcus epidermidis. This invention involves a new fibrinogen binding protein or polypeptide, which is produced through biotechnological methods. The patent also covers a recombinant DNA molecule coding for the protein, as well as micro-organisms containing this recombinant DNA. The therapeutic and diagnostic uses of this protein and DNA are significant, including the development of a diagnostic kit for determining the presence and type of coagulase-negative staphylococci, as well as a vaccine composition. Another notable patent involves a collagen binding protein and its preparation, which relates to a new recombinant DNA molecule comprising a nucleotide sequence from Staphylococcus aureus coding for a protein with collagen binding properties.
Career Highlights
Throughout his career, Martin K Lindberg has worked with various companies, including Alfa Laval Corporation. His expertise in biotechnology has allowed him to contribute to innovative projects that advance the field.
Collaborations
Lindberg has collaborated with notable individuals in his field, including Magnus Hook and Lars Christer Signas. These collaborations have further enriched his research and development efforts.
Conclusion
Martin K Lindberg is a distinguished inventor whose work in biotechnology continues to pave the way for advancements in medical diagnostics and therapeutics. His innovative patents reflect his commitment to improving healthcare through scientific discovery.